RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      검색결과 좁혀 보기

      선택해제

      오늘 본 자료

      • 오늘 본 자료가 없습니다.
      더보기
      • 무료
      • 기관 내 무료
      • 유료
      • KCI등재

        The Dark Side of 5α-Reductase Inhibitors’ Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression

        Abdulmaged M. Traish,Ashwini Mulgaonkar,Nicholas Giordano 대한비뇨의학회 2014 Investigative and Clinical Urology Vol.55 No.6

        With aging, abnormal benign growth of the prostate results in benign prostate hyperplasia(BPH) with concomitant lower urinary tract symptoms (LUTS). Because theprostate is an androgen target tissue, and transforms testosterone into 5α-dihydrotestosterone(5α-DHT), a potent androgen, via 5α-reductase (5α-R) activity, inhibitingthis key metabolic reaction was identified as a target for drug development to treatsymptoms of BPH. Two drugs, namely finasteride and dutasteride were developed asspecific 5α-reductase inhibitors (5α-RIs) and were approved by the U.S. Food and DrugAdministration for the treatment of BPH symptoms. These agents have proven usefulin the reducing urinary retention and minimizing surgical intervention in patients withBPH symptoms and considerable literature exists describing the benefits of theseagents. In this review we highlight the adverse side effects of 5α-RIs on sexual function,high grade prostate cancer incidence, central nervous system function and ondepression. 5α-Rs isoforms (types 1–3) are widely distributed in many tissues includingthe central nervous system and inhibition of these enzymes results in blockade of synthesisof several key hormones and neuro-active steroids leading to a host of adverseeffects, including loss of or reduced libido, erectile dysfunction, orgasmic dysfunction,increased high Gleason grade prostate cancer, observed heart failure and cardiovascularevents in clinical trials, and depression. Considerable evidence exists frompreclinical and clinical studies, which point to significant and serious adverse effectsof 5α-RIs, finasteride and dutasteride, on sexual health, vascular health, psychologicalhealth and the overall quality of life. Physicians need to be aware of such potential adverseeffects and communicate such information to their patients prior to commencing5α-RIs therapy.

      연관 검색어 추천

      이 검색어로 많이 본 자료

      활용도 높은 자료

      해외이동버튼